Verastem (VSTM) Cash from Operations (2011 - 2026)
Verastem's (VSTM) quarterly Cash from Operations came in at 52116000.0 in Q1 2026, down 34.75% year-on-year from 79871549.22 in Q1 2025, and down 73.99% quarter-over-quarter from 29954000.0 in Q4 2025.
Verastem (VSTM) Cash from Operations (2011 - 2026) Analysis & Trends
Verastem's Cash from Operations history runs 16 years deep, the most recent figure standing at 52116000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 34.75% year-over-year to 52116000.0 in Q1 2026; TTM through Mar 2026 was 150949000.0, a 31.1% decrease from a year earlier, with the FY2025 full-year figure at 137509000.0, down 31.25% from the prior year.
- Cash from Operations declined to 52116000.0 in Q1 2026 per VSTM's latest filing, from 29954000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 12694000.0 in Q2 2022 and bottomed at 52116000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 25099000.0 (2024), against an average of 26148764.71.
- Across the five-year window, Cash from Operations sank 78.63% in 2023 and grew 15.44% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 16616000.0 in 2022, then sank by 78.63% to 29681000.0 in 2023, then rose by 15.44% to 25099000.0 in 2024, then declined by 19.34% to 29954000.0 in 2025, then tumbled by 73.99% to 52116000.0 in 2026.
- Per Business Quant, the three latest VSTM Cash from Operations figures stand at 52116000.0 (Q1 2026), 29954000.0 (Q4 2025), and 36216000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn | -52.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.12 Mn |
| Mar 31, 2026 | -52.12 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Jun 30, 2024 | -27.57 Mn |
| Jun 30, 2024 | -27.57 Mn |
| Mar 31, 2024 | -28.31 Mn |
| Mar 31, 2024 | -28.31 Mn |
| Dec 31, 2023 | -29.68 Mn |
| Dec 31, 2023 | -29.68 Mn |